The FDA Advisory Committee met in March 2018 to discuss CiPA. See full details, a transcript and more online here.
Slides from the CiPA 2018 Meeting are available online as well as the meeting synopsis.
CiPA Quarterly Updates!
The CiPA Steering Team recently instituted quarterly updates to share the latest happenings with interested stakeholders. Check out the June update here and look forward to the next update in September.
Check out the latest Science article featuring CiPA:
The CiPA initiative began following a workshop in July 2013 at the US FDA. The objective of the CIPA initiative is to engineer an assay for assessment of the proarrhythmic potential of new drugs that has improved specificity compared with the hERG assay plus Thorough QT study.
HESI can provide more details
about CiPA and CiPA workstreams.